Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.0370
-0.0009 (-2.37%)
Apr 15, 2026, 4:00 PM EST
Bioxytran Employees
Bioxytran had 3 employees as of December 31, 2023. The number of employees increased by 1 or 50.00% compared to the previous year.
Employees
3
Change (1Y)
1
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
4.97M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2023 | 3 | 1 | 50.00% |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | 0 | - |
| Dec 31, 2020 | 2 | 0 | - |
| Dec 31, 2019 | 2 | 0 | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| NKGen Biotech | 26 |
| Mosaic ImmunoEngineering | 8 |
| Galera Therapeutics | 3 |
| AccuStem Sciences | 2 |
| Synlogic | 1 |
Bioxytran News
- 27 days ago - BIOXYTRAN, INC. COMPLETES $1.2 MILLION PRIVATE PLACEMENT - GlobeNewsWire
- 6 weeks ago - Bioxytran Announces Positive Dose Optimization Results and Advances Toward Phase 3 Registrational Trial for ProLectin-M - GlobeNewsWire
- 6 weeks ago - Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19 - Accesswire
- 2 months ago - Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran - GlobeNewsWire
- 2 months ago - Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics - GlobeNewsWire
- 5 months ago - Bioxytran Announces Initiation of Coverage of its Stock by Independent Research - GlobeNewsWire
- 6 months ago - Bioxytran Completes Randomized Clinical Trial For its Broad-Spectrum Antiviral Drug - GlobeNewsWire
- 8 months ago - Bioxytran Unveils Revolutionary Precision Diagnostics on Tissue Oxygenation - GlobeNewsWire